Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.600
-0.150 (-4.00%)
At close: Apr 16, 2026, 4:00 PM EDT
3.660
+0.060 (1.67%)
Pre-market: Apr 17, 2026, 5:46 AM EDT
Recursion Pharmaceuticals Employees
Recursion Pharmaceuticals had 600 employees as of December 31, 2025. The number of employees decreased by 200 or -25.00% compared to the previous year.
Employees
600
Change (1Y)
-200
Growth (1Y)
-25.00%
Revenue / Employee
$124,468
Profits / Employee
-$1,074,598
Market Cap
1.90B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 600 | -200 | -25.00% |
| Dec 31, 2024 | 800 | 300 | 60.00% |
| Sep 30, 2024 | 500 | -50 | -9.09% |
| Jun 30, 2024 | 500 | -50 | -9.09% |
| Mar 31, 2024 | 500 | 0 | - |
| Dec 31, 2023 | 500 | 0 | - |
| Sep 30, 2023 | 550 | 50 | 10.00% |
| Jun 30, 2023 | 550 | 100 | 22.22% |
| Mar 31, 2023 | 500 | 50 | 11.11% |
| Dec 31, 2022 | 500 | 100 | 25.00% |
| Sep 30, 2022 | 500 | 170 | 51.52% |
| Jun 30, 2022 | 450 | 180 | 66.67% |
| Mar 31, 2022 | 450 | 232 | 106.42% |
| Dec 31, 2021 | 400 | 69 | 20.85% |
| Sep 30, 2021 | 330 | -1 | -0.30% |
| Jun 30, 2021 | 270 | - | - |
| Mar 31, 2021 | 218 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Galapagos NV | 558 |
| Agios Pharmaceuticals | 540 |
| Ocular Therapeutix | 325 |
| Zymeworks | 264 |
| Capricor Therapeutics | 231 |
| Stoke Therapeutics | 170 |
| Pharvaris | 129 |
| AnaptysBio | 104 |
RXRX News
- 9 days ago - Recursion to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform - GlobeNewsWire
- 22 days ago - Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer - GlobeNewsWire
- 7 weeks ago - Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Recursion To Be Featured in HighRes' Lightning Talk at NVIDIA GTC - GlobeNewsWire
- 2 months ago - Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25 - GlobeNewsWire
- 2 months ago - Applied Digital, Recursion Pharmaceuticals Stocks Drop. Blame Nvidia. - Barrons
- 3 months ago - Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire